ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

IOM Report: Nationwide Crisis Facing Cancer Care

September 13, 2013

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

Administration to Request 3.9% Increase for NIH; 1.3% Raise For NCI In FY97

March 8, 1996

Creating the Modern Cancer Center

November 2, 2021

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999